EATG » FDA approves SYMTUZA

FDA approves SYMTUZA

Janssen announces U.S. FDA approval of SYMTUZA (D/C/F/TAF), the first and only complete darunavir-based single-tablet regimen for the treatment of HIV-1 infection

Read the press release here.

Source:
Johnson & Johnson
News categories: HIV treatment, EMA/FDA